@article{3033280,
    title = "Exacerbation of bronchiectasis by Pseudomonas putida complicating
COVID-19 disease: A case report",
    author = "Georgakopoulou, Vasiliki Epameinondas and Avramopoulos, Pantelis and and Papalexis, Petros and Bitsani, Aikaterini and Damaskos, Christos and and Garmpi, Anna and Gkoufa, Aikaterini and Garmpis, Nikolaos and and Mantzouranis, Konstantinos and Chlapoutakis, Serafeim and Sklapani, and Pagona and Trakas, Nikolaos and Spandidos, Demetrios A.",
    journal = "Experimental and Therapeutic Medicine",
    year = "2021",
    volume = "22",
    number = "6",
    publisher = "SPANDIDOS PUBL LTD",
    issn = "1792-0981, 1792-1015",
    doi = "10.3892/etm.2021.10887",
    keywords = "bronchiectasis; disease exacerbation; coronavirus; infection;
immunocompetence",
    abstract = "Novel coronavirus infection presents with greater severity in
individuals with comorbid chronic lung diseases. Bronchiectasis is an
illness characterized by permanent enlargement of the airways,
presenting with chronic cough and sputum production and vulnerability to
lung infections. Bronchiectasis is not a common comorbid disease in
patients with COVID-19 disease and bronchiectasis exacerbation rates
were decreased during the pandemic. However, COVID-19 disease is
associated with worse outcomes in patients with bronchiectasis and
patients with bronchiectasis are more susceptible to SARS-CoV-2
infection development. Pseudomonas putida is an opportunistic pathogen,
causing infections mostly in immunocompromised hosts and is not a
frequent bacterial colonizer in patients with bronchiectasis. This
present study reports a rare case of exacerbation of bronchiectasis by
Pseudomonas putida complicating COVID-19 disease in an immunocompetent
70-year-old woman. Clinicians should be aware that SARS-CoV-2 infection
is probably a precipitating factor of bronchiectasis exacerbation while
bronchiectasis is a risk factor for greater severity of SARS-CoV-2
infection."
}